000 | 01032 a2200289 4500 | ||
---|---|---|---|
005 | 20250516165230.0 | ||
264 | 0 | _c20131119 | |
008 | 201311s 0 0 eng d | ||
022 | _a1879-3185 | ||
024 | 7 |
_a10.1016/j.tox.2013.08.011 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVinken, Mathieu | |
245 | 0 | 0 |
_aThe adverse outcome pathway concept: a pragmatic tool in toxicology. _h[electronic resource] |
260 |
_bToxicology _cOct 2013 |
||
300 |
_a158-65 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCholestasis _xchemically induced |
650 | 0 | 4 |
_aFatty Liver _xchemically induced |
650 | 0 | 4 |
_aHepatic Stellate Cells _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aSkin _xdrug effects |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aToxicology _xmethods |
773 | 0 |
_tToxicology _gvol. 312 _gp. 158-65 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tox.2013.08.011 _zAvailable from publisher's website |
999 |
_c23034732 _d23034732 |